報價延遲最少15分鐘:2025/01/21 19:11 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
395.85 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
9.33/14.56
|
|
企業價值
157.07B
|
| 資產負債 |
|
每股賬面淨值
52.85
|
| 現金流量 |
|
現金流量率
0.03
|
| 損益表 |
|
收益
20.50B
|
|
每股收益
52.16
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 19:11 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just overone fourth of Stryker's total revenue currently comes from outside the United States. |